Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-01-14

FDA Approved: SAVELLA — Original Application (Allergan, Inc.)

View source ↗

Summary

FDA approved SAVELLA (milnacipran hydrochloride) under an original application by Allergan, Inc. for the treatment of fibromyalgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAVELLA (milnacipran hydrochloride)

Snippet

ORIG AP for SAVELLA (MILNACIPRAN HYDROCHLORIDE)